Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company ...

Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat ...

Hologic (HOLX) delivered earnings and revenue surprises of 0.98% and 0%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

The company guided Q2 2025 revenues to be between $995 million and $1.005 billion, with non-GAAP EPS expected in the range of $1 to $1.03. Full-year revenue guidance was revised to $4.05 billion to $4 ...

BTIG analyst Ryan Zimmerman maintained a Hold rating on Hologic (HOLX – Research Report) yesterday. The company’s shares closed yesterday at ...

Q1 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate Vice President, ...

While reporting its results for the first quarter, Hologic, Inc. (HOLX) revised its outlook for the full year 2025. Looking forward ...

Hologic Inc (NASDAQ:HOLX). reported its financial results for the first quarter of fiscal year 2025, showing a slight beat in earnings per share (EPS) but falling short on revenue expectations. The ...

MARLBOROUGH, Mass. - Medical (TASE:PMCN) technology company Hologic, Inc. (NASDAQ:HOLX) reported mixed fiscal first quarter results and provided weaker-than-expected guidance for the current quarter, ...

Elise Mertens clinches singles title at inaugural Singapore Tennis Open data-link= Mertens clinches singles title at inaugural Singapore ...

Stock indexes today are under pressure due to weakness in megacap technology stocks stemming from disappointing earnings.  Alphabet is down more than -7% after reporting weaker-than-expected Q4 ...

Salesforce , the #1 AI CRM, today announced that its fourth quarter and full year fiscal 2025 results will be released on Wednesday, Feb. 26, 2025, after the close of the market. The company will host ...